Literature DB >> 19561788

The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease.

S A Polyzos, J Kountouras, Ch Zavos.   

Abstract

Entities:  

Keywords:  adipocytokine; adiponectin; free fatty acids; insulin resistance; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; tumor necrosis factor

Year:  2009        PMID： 19561788      PMCID： PMC2683459     

Source DB:  PubMed          Journal:  Hippokratia        ISSN： 1108-4189            Impact factor:   0.471


× No keyword cloud information.
  5 in total

Review 1.  Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance.

Authors:  Herbert Tilg; Gökhan S Hotamisligil
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

2.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

3.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

Authors:  Aimin Xu; Yu Wang; Hussila Keshaw; Lance Yi Xu; Karen S L Lam; Garth J S Cooper
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 4.  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos Zavos
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

5.  Non alcoholic fatty liver disease and metabolic syndrome.

Authors:  P Paschos; K Paletas
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471
  5 in total
  19 in total

Review 1.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

2.  Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometry.

Authors:  John T Barr; Jeffrey P Jones; Carolyn A Joswig-Jones; Dan A Rock
Journal:  Mol Pharm       Date:  2013-09-19       Impact factor: 4.939

Review 3.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

4.  Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease.

Authors:  Amirhossein Sahebkar
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

5.  Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.

Authors:  Runbin Sun; Na Yang; Bo Kong; Bei Cao; Dong Feng; Xiaoyi Yu; Chun Ge; Jingqiu Huang; Jianliang Shen; Pei Wang; Siqi Feng; Fei Fei; Jiahua Guo; Jun He; Nan Aa; Qiang Chen; Yang Pan; Justin D Schumacher; Chung S Yang; Grace L Guo; Jiye Aa; Guangji Wang
Journal:  Mol Pharmacol       Date:  2016-12-08       Impact factor: 4.436

Review 6.  Ghrelin and liver disease.

Authors:  Mar Quiñones; Johan Fernø; Omar Al-Massadi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

7.  Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Erina Kumagai; Yohei Mano; Sachiyo Yoshio; Hirotaka Shoji; Masaya Sugiyama; Masaaki Korenaga; Tsuyoshi Ishida; Taeang Arai; Norio Itokawa; Masanori Atsukawa; Hideyuki Hyogo; Kazuaki Chayama; Tomohiko Ohashi; Kiyoaki Ito; Masashi Yoneda; Takumi Kawaguchi; Takuji Torimura; Yuichi Nozaki; Sumio Watanabe; Masashi Mizokami; Tatsuya Kanto
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

8.  Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Authors:  Roya Rafie; Seyed Ahmad Hosseini; Eskandar Hajiani; Amal Saki Malehi; Seyed Ali Mard
Journal:  Clin Exp Gastroenterol       Date:  2020-01-23

9.  Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy.

Authors:  Jia Xiao; Rui Guo; Man-Lung Fung; Emily C Liong; Raymond Chuen Chung Chang; Yick-Pang Ching; George L Tipoe
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-19       Impact factor: 2.629

Review 10.  Molecular Pathogenesis of NASH.

Authors:  Alessandra Caligiuri; Alessandra Gentilini; Fabio Marra
Journal:  Int J Mol Sci       Date:  2016-09-20       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.